FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely oncology, and can be used for determining time to lung cancer progression. For this purpose, lung tumour tissue after curative resection and intact lung tissue obtained from a tumour remote site are analysed for a prolactin level, and if observing the value increasing in 1.5 times or more relatively to that in the intact lung tissue the generalised process and the onset of metastatic lung cancer to remote organs within 6 months is predicted.
EFFECT: method allows the objective assessment of the pathological process directionality, the well-timed prediction of the generalised cancer and taking adequate therapeutic measures.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING DEVELOPMENT OF CEREBRAL METASTASES IN CASE OF LUNG CANCER IN WOMEN | 2009 |
|
RU2439579C2 |
| METHOD FOR SPECIFYING DIRECTIONALITY OF PATHOLOGICAL PROCESS IN MUCINOUS GASTRIC CARCINOMA | 2012 |
|
RU2480771C1 |
| METHOD FOR PREDICTION OF LIVER METASTASES IN RECTAL CANCER | 2014 |
|
RU2585122C1 |
| METHOD FOR PREDICTION OF DEVELOPING METASTASES IN PATIETNS SUFFERING RECTAL CANCER | 2009 |
|
RU2420742C1 |
| METHOD FOR PREDICTION OF DURATION OF RECURRENCE-FREE INTERVAL IN PATIENTS WITH RECTAL CANCER | 2009 |
|
RU2415429C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE IN DISSEMINATED SKIN MELANOMA PATIENTS | 2008 |
|
RU2399057C1 |
| METHOD OF PREDICTING CHEMORADIOTHERAPY EFFICIENCY IN PATIENTS WITH DISSEMINATED SKIN MELANOMA | 2008 |
|
RU2398238C1 |
| METHOD FOR PREDICTING METASTASES IN PATIENTS WITH SKIN MELANOMA | 2014 |
|
RU2546035C1 |
| METHOD OF CONTROL OF EFFICIENCY OF ANTITUMOR TREATMENT OF WOMEN WITH MALIGNANT GENITALIA TUMORS | 1999 |
|
RU2170433C2 |
| METHOD FOR PREDICTING RELAPSE DEVELOPMENT AT UTERINE BODY CANCER | 2002 |
|
RU2250077C2 |
